Details of the Drug Formulation (DFM)
General Information of DFM (ID: F23502) | |||||
---|---|---|---|---|---|
Name |
Oxybutynin 3.9mg extended release film
|
||||
Company |
Allergan
|
||||
Active Pharmaceutical Ingredient (API) | Oxybutynin | API Info click to show the detail info of this API | |||
Overactive bladder | ICD-11: GC50 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0Q3UJ | DIG Info | Acrylic acid | Other agent | ||
E0T2AJ | DIG Info | Triacetin | Humectant ... | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Transferase (TFase) | ||||||
DBT Name: Choline acetylase (CHAT) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Acrylic acid | |||||
Biological Activity | IC50 < 200000 nM (tested by experiment) | [1] | ||||
Tested Species | Rattus norvegicus (Rat) | |||||
UniProt ID | CLAT_RAT | |||||
References | |||||
---|---|---|---|---|---|
1 | Chemistry and biological activities of N,N-dimethylaminoethyl acrylate, a choline acetyltransferase inhibitor. J Med Chem. 1976 Feb; 19(2):300-3. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.